References
Bertrand, J.J.; Waine, H. and Tobias, C.A.: Distribution of gold in the animal body in relation to arthritis. Journal of Laboratory and Clinical Medicine 33: 1133–1138 (1948).
Blau, S.P.: Metabolism of gold during lactation. Arthritis and Rheumatism 16: 777–778 (1973).
Block, W.D.; Buchanan, O.H. and Freyberg, R.H.: Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. IV. Studies of the absorption, distribution and excretion of gold following the intramuscular injection of gold thioglucose and gold calcium thiomalate. Journal of Pharmacology and Experimental Therapeutics 76: 355–357 (1942).
Cahill, R.N.P.: Effects of sodium aurothiomalate ‘Myochrysine’ on DNA synthesis in phytohemagglutinin-stimulated cultures of sheep lymphocytes. Experientia 27: 913–914 (1970).
Campion, D.S.; Olson, R.; Bohan, A. and Bluestone, R.: Interaction of gold sodium thiomalate (Myochrysine) with serum albumin. Journal of Rheumatology, Supplement 1 (Abstract) 1: 112 (1974).
Cox, A.J. and Marich, K.W.: Gold in the dermis following gold therapy for rheumatoid arthritis. Archives of Dermatology 108: 655–657 (1973).
Empire Rheumatism Council Research Sub-committee: Gold therapy in rheumatoid arthritis: Report of a multi-centre controlled study. Annals of the Rheumatic Diseases 19: 95–117 (1960).
Empire Rheumatism Council Research Sub-committee: Gold therapy in rheumatoid arthritis: Final report of a multi-centre controlled trial. Annals of the Rheumatic Diseases 20: 315–333 (1961).
Freyberg, R.H.; Block, W.D. and Levy, S.: Metabolism, toxicity and manner of action of gold compounds used in treatment of arthritis: I. Human plasma and synovial fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulfate, and collodial gold sulfide. Journal of Clinical Investigation 20: 401–412 (1941).
Gerber, R.C.; Paulus, H.E.; Bluestone, R. and Lederer, M.: Kinetics of aurothiomalate in serum and synovial fluid. Arthritis and Rheumatism 15: 625–629 (1972a).
Gerber, R.C.; Paulus, H.E.; Bluestone, R. and Pearson, C.M.: Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Annals of the Rheumatic Diseases 31: 308–310 (1972b).
Gerber, R.C.; Paulus, H.E.; Jennrich, R.I.; Lederer, M.; Bluestone, R.; Blahd, W.H. and Pearson, C.M.: Gold kinetics following aurothiomalate therapy: Use of a whole-body radiation counter. Journal of Laboratory and Clinical Medicine 83: 778–789 (1974).
Gottlieb, N.L.; Smith, P.M. and Smith, E.M.: Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis. Arthritis and Rheumatism 15: 582–592 (1972).
Gottlieb, N.L.; Smith, P.M. and Smith, E.M.: Pharmacodynamics of 197Au and 195Au labelled aurothiomalate in blood. Arthritis and Rheumatism 17: 171–183 (1974).
Gottlieb, N.L.; Kiem, I.M.; Penneys, N.S. and Schultz, D.R.: The influence of chrysotherapy on serum protein and immunoglobulin levels, rheumatoid factor, and antiepithelial antibody titers. Journal of Laboratory and Clinical Medicine 86: 962–972 (1975).
Grahame, R.; Billings, R.; Laurence, M.; Marks, V. and Wood, P.J.: Tissue gold levels after chrysotherapy. Annals of the Rheumatic Diseases 33: 536–539 (1974).
Harth, M.: Serum gold levels during chrysotherapy with relation to urinary and fecal excretion. Clinical Pharmacology and Therapeutics 15: 354–360 (1974).
Harth, M.; Stiller, C.; McGirr, D.; Evans, J. and Sinclair, N.: Effects of sodium aurothiomalate (SATM) on lymphocyte responses in normal man and patients with rheumatoid arthritis (RA). Abstract. Journal of Rheumatology 3: 100 (1976).
Jeffrey, J.R.; Freundlich, H.F. and Bailey, D.M.: Distribution and excretion of radiogold in animals. Annals of the Rheumatic Diseases 17: 52–60 (1958).
Jessop, J.D. and Johns, R.G.S.: Serum gold determination in patients with rheumatoid arthritis receiving sodium aurothiomalate. Annals of the Rheumatic Diseases 32: 228–232 (1973).
Jessop, J.D.; Vernon-Roberts, B. and Harris, J.: Effects of gold salts and prednisolone on inflammatory cells. Annals of the Rheumatic Diseases 32: 294–300 (1973).
Jones, R.A.; Ahmed, M.W. and Chan, B.W.B.: Gold excretion in rheumatoid arthritis. British Medical Journal 1: 610 (1971).
Krusius, F.E.; Markkanen, A. and Peltola, P.: Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 29: 232–235 (1970).
Lawrence, J.S.: Studies with radioactive gold. Annals of the Rheumatic Diseases 20: 341–352 (1961)
Levy, G.: Kinetics of pharmacologic effects. Clinical Pharmacology and Therapeutics 7: 362–372 (1966).
Lorber, A.: Pharmacological application of chrysotherapy: Inhibitory effect on acid hydrolase activity of synovial fluid. Arthritis and Rheumatism 11: 495 (1968) (Abstract).
Lorber, A.; Cohen, R.L.; Chang, C.C. and Anderson, H.E.: Gold determination in biological fluids by atomic absorption spectrophotometry: Application to chrysotherapy in rheumatoid arthritis patients. Arthritis and Rheumatism 11: 170–177 (1968).
Lorber, A.; Bovy, R.A. and Chang, C.C.: Relationship between serum gold content and distribution to serum immunoglobulins and complement. Nature New Biology 236: 250–252 (1972).
Lorber, A.; Atkins, C.J.; Chang, C.C.; Lee, Y.B.; Starrs, J. and Boyy, R.A.: Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis. Annals of the Rheumatic Diseases 32: 133–139 (1973).
Lorber, A.; Chandor, S.B.; Simon, T.M.; Leeb, J. and Carroll, Jr., P.E.: Immunosuppressive action of gold salts in rheumatoid arthritis. Journal of Rheumatology (Abstract) Supplement 1, 1:112 (1974).
Lorber, A.; Simon, T.M.; Leeb, J. and Carroll, P.E.: Chrysotherapy: Pharmacological and clinical correlates. Journal of Rheumatology 2: 401–410 (1975).
Lorber, A.: Pharmacokinetics and effector availability of gold compounds; in Sutton (Ed) Gold Therapy in Arthritis (Marcel Dekker, New York, in Press 1977a).
Lorber, A.; Simon, T. and Wilcox, S.: In vivo gold kinetics —lymphocyte binding and effect on lymphocyte responsiveness. Arthritis and Rheumatism 20: 126 (1977b).
Mascarenhas, B.R.; Granda, J.L. and Freyberg, R.H.: Gold metabolism in patients with rheumatoid arthritis treated with gold compounds — reinvestigated. Arthritis and Rheumatism 15: 391–402 (1972).
McQueen, E.G. and Dykes, P.W.: Transport of gold in the body. Annals of the Rheumatic Diseases 28: 437–442 (1969).
Mohr, W.; Hersener, J. and Richter, R.: The localization of gold in the joints of patients with rheumatoid arthritis after chrysotherapy. Zeitschriff fur Rheumatologie 33: 369–375 (1974).
Norton, W.L.; Lewis, D.C. and Ziff, M.: Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis and Rheumatism 11: 436–443 (1968).
Rubinstein, H.M. and Dietz, A.A.: Serum gold. II. Levels in rheumatoid-arthritis. Annals of the- Rheumatic Diseases 32: 128–132 (1973).
Smith, R.T.; Peak, W.T.; Kron, K.M.; Hermann, I.F.; DelToro, R.A. and Goldman, M.: Increasing the effectiveness of gold therapy in rheumatoid arthritis. Journal of the American Medical Association 167: 1197–1204 (1958).
Smith, P.M.; Smith, E.M. and Gottlieb, N.L.: Gold distribution in whole blood during chrysotherapy. Journal of Laboratory and Clinical Medicine 82: 930–937 (1973).
Solvsten, S.: Determination of gold in serum and urine by neutron activation analysis. Scandinavian Journal of Clinical and Laboratory Investigation 16: 39–44 (1964).
Withey, R.J.: Bioavailability and therapeutic efficacy. Revue Canadienne de Biologie 32: 21–30 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lorber, A. Monitoring Gold Plasma Levels in Rheumatoid Arthritis. Clin Pharmacokinet 2, 127–146 (1977). https://doi.org/10.2165/00003088-197702020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197702020-00004